CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2020; 24(03): e388-e390
DOI: 10.1055/s-0040-1713141
Letter to the Editor
Special Article COVID-19
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

The Italian Society Indication for Rhinologists during Covid-19: Italy Phase 2

1   Otorhinolaryngology, Head and Neck Surgery Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
2   IFOS Former President and Executive Board member, Rome, Italy
3   ENT Clinic, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
4   Department of Neuroscience, Reproductive and Odontostomatological Sciences - ENT Section, Università degli Studi di Napoli Federico II, Naples, Italy
› Author Affiliations
Further Information

Publication History

07 May 2020

11 May 2020

Publication Date:
19 June 2020 (online)

Dear Editor,

SARS-CoV-2 is highly contagious, with a huge impact on the healthcare systems worldwide; medical staff, and rhinologists in particular, are at high risk of viral contamination. Indeed, due to the exposure of airway and mucosal surfaces and the possibility of generating aerosols, many head and neck, as well as otolaryngologic oral diagnostic, and surgical procedures are high-risk. Therefore, the Italian Rhinologic Society proposed some brief and clear indications to go through the so called “fase 2” (“phase 2”) in our country.

Italian Rhinologic Society Board - (

Bellussi, Luisa: IFOS executive board member, Rome, Italy (

Cassano, Pasquale: Otorhinolaryngology, Università degli Studi di Foggia (

Piemonte, Marco: ENT, Azienda Ospedaliera Universitaria, Udine (

Scasso, Felice: ENT, Ospedale “Antero Micone” Asl 3 Genovese (

Albera, Roberto: ENT, Università degli Studi di Torino (

Bellocchi, Gianluca: ENT, Ospedale San Camillo, Rome (

Della Vecchia, Laura: ENT, Azienda Ospedaliera-Universitaria “Ospedale Di Circolo E Fondazione Macchi” (

Salamanca, Fabrizio: ENT, Casa di Cura Humanitas San Pio X (

The members of the Italian Rhinologic Society board participated in the authorship of this article and are listed on page 2.

  • References

  • 1 Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncol 2020; 105: 104724 . Doi: 10.1016/j.oraloncology.2020.104724
  • 2 Leboulanger N, Sagardoy T, Akkari M. , et al; French Association of Pediatric Otorhinolaryngology (AFOP); French Society of Otorhinolaryngology; Head, Neck Surgery (SFORL); Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL). COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis 2020; ••• :S1879-7296(20)30100-9 DOI: 10.1016/j.anorl.2020.04.010.
  • 3 Givi B, Schiff BA, Chinn SB. , et al. Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Head Neck Surg 2020; ••• DOI: 10.1001/jamaoto.2020.0780.
  • 4 Fakhry N, Schultz P, Morinière S. , et al; French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL); French Society of Head and Neck Carcinology (SFCCF). French consensus on management of head and neck cancer surgery during COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis 2020; ••• :S1879-7296(20)30098-3 DOI: 10.1016/j.anorl.2020.04.008.